Murthy, Rashmi K.
Royal Marsden NHS Foundation Trust · The University of Texas MD Anderson Cancer Center · University of California, Los Angeles · Peter MacCallum Cancer Centre · Edinburgh Cancer Research · Sarah Cannon · Vanderbilt University Medical Center
2 papers on CoChatORCID 0000-0002-0103-4718
Most cited papers
- Verified
Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer
Murthy, R. K., Loi, S., Okines, A., Paplomata, E., Hamilton, E., Hurvitz, S. A., Lin, N. U., Borges, V., Abramson, V., Anders, C., et al. (2020) · New England Journal of Medicine
HER2/EGFR in Cancer ResearchGastric Cancer Management and Outcomes
Cited by 1,326
- Verified
Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER2CLIMB trial
Lin, N. U., Borges, V., Anders, C., Murthy, R. K., Paplomata, E., Hamilton, E., Hurvitz, S., Loi, S., Okines, A., Abramson, V., et al. (2020) · Journal of Clinical Oncology
Brain Metastases and TreatmentHER2/EGFR in Cancer Research
Cited by 544
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free